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Abstract: Patients with hypogammaglobulinemia are susceptible to recurrent bacterial, viral, fungal, and parasitic infections. 
The most common clinical manifestation includes recurrent severe infections caused by encapsulated bacteria, in which 
antibody opsonization is the primary defense mechanism. To our knowledge, this is the first case report of  hypogammaglob-
ulinemia in a Ugandan child in Sub-Saharan Africa. The case emphasizes the importance of  including hypogammaglobuline-
mia in the differential diagnosis for children presenting with a history of  recurrent infections. 
Aim: To raise the index of  clinical suspicion of  hypogammaglobulinemia in an African child and allow for prompt recogni-
tion and management of  hypogammaglobulinemia.
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Introduction
The most common worldwide causes of  immuno-
deficiency include HIV, malnutrition, and immuno-
suppressive agents. However, when HIV infection, 
malnutrition, and other secondary causes of  hypogam-
maglobulinemia have been excluded, it is important to 
consider a primary cause of  hypogammaglobulinemia. 
Primary humoral immunodeficiencies are characterized 
by recurrent, severe upper and lower respiratory tract 
infections due to encapsulated bacteria.  Although the 
incidence of  hereditary immunodeficiency is low when 
compared to acquired immunodeficiency, the preva-
lence of  people affected by a primary immunodeficien-
cy is as high as 1 in 500 persons1. We report a case of  a 
9 year old Ugandan boy with the diagnosis of   hypog-
ammaglobulinemia. 
Case Report
A 9-year-old African boy first presented to Mulago hos-
pital in Kampala, Uganda at the age of  5 years with 
increasingly frequent and severe recurrent respiratory 
tract infections since infancy. The infections started 
with a measles-like illness at 3 months of  age, which 
had responded to broad spectrum antibiotics. He devel-
oped bacterial meningitis at the age of  two, which was 
successfully treated. He has had a history of  recurrent 
severe pneumonia’s approximately two per year since 
age 2.
At age 4, chest radiograph and computer tomography 
of  the chest revealed multi-segmental consolidation and 
collapse of  the right middle lobe. He was given several 
courses of  antibiotics with no improvement in symp-
toms. The recurrent episodes of  pneumonia persisted. 
Six months later the patient underwent a right middle 
lobectomy for persistent pneumonia unresponsive to 
medical treatment. Pathology revealed localized bron-
chiectasis with atelectasis and negative cultures. Despite 
the lobectomy, the recurrent respiratory tract infections 
did not subside.
After the lobectomy, he required several hospitaliza-
tions, including episodes of  septic arthritis of  the left 
knee joint and of  pyogenic meningitis. Repeated HIV 
testing on the child and parents were negative. Immu-
noglobulin studies were sent to the USA to aid in di-
African Health Sciences Vol 15 Issue 1, March 2015299
agnosis. Rate nelphelometry was used to measure Ig 
concentrations on a Beckman Coulter IMMAGE® 800 
Analzyer. It revealed deficiency of  immunoglobulins 
IgG, IgM, and IgA with values of  28 mg/dL (normal 
565 - 1765 mg/dL), 14 mg/dL (normal 55 - 375mg/dL) 
, and <7 mg/dL (85 - 385 mg/dL) respectively.
On physical exam, he was small for his age, but oth-
erwise in fair condition. He had somewhat labored 
breathing and coarse crepitations, more marked on the 
right upon posterior chest auscultation. Heart sounds 
were normal with no murmurs. There was no cervical, 
supraclavicular, or inguinal lymphadenopathy. Abdo-
men showed no splenomegaly or masses. Skin was free 
of  neurocutaneous stigmata, rashes or bruises.
Neurologic exam was intact.
This child’s extensive history of  chronic infections, 
physical exam findings, imaging studies, and lab tests 
suggest a diagnosis of  hypogammaglobulinemia. The 
child was given Septra for prophylaxis, since IVIG was 
too costly and not available. The child is alive to date.
Discussion
While normal healthy children may have up to six upper 
respiratory tract infections in a given year2, infections 
will normally either clear relatively quickly or respond 
well to antibiotics. Patients with hypogammaglobuline-
mia are susceptible to recurrent and severe bacterial, vi-
ral, fungal, and parasitic infections. Symptoms typically
begin around 6 months of  age when concentrations of  
maternal IgG antibodies decrease.
Children often have associated findings of  failure to 
thrive, recurrent fevers, and chronic diarrhea. Because 
of  a decrease in immunoglobulins and thus decrease in 
antibody oposinization, patients with hypogammaglob-
ulinemia have an increased susceptibility to encapsulat-
ed bacteria. Patients present with sepsis, septic arthritis, 
CNS infections, and osteomylelitis due to encapsulated 
organisms . Gastroenteritis infections are also common-
ly caused by Salmonella and Campylobacter. Patients 
may also present with severe hepatitis B, viral enceph-
alitis, and bacterial meningitis3. Roughly two-thirds of
patients affected with primary hypogammaglobulinemia 
will have lymphoid hyperplasia manifesting in the liver, 
spleen, tonsils, or peripheral nodes4. Because of  chronic 
immune activation, hepatosplenomegaly may be pres-
ent. Findings of  hypoplasia in tissue usually rich in B 
lymphocytes will be present in patients with X-linked 
agammaglobulinemia. Autoimmune diseases, including 
diabetes mellitus, rheumatoid arthritis, and inflammato-
ry bowel disease, have been observed in patients with 
hypogammaglobulinemia.
All forms of  hypogammaglobuinemia have similar clin-
ical presentations and are primarily distinguished from 
each other based on Ig levels. X-linked agammaglobu-
linemia (XLA) initially begins between 6 to 18 months 
of  age and is due to a defect in Bruton’s tyrosine kinase. 
Patients present with recurrent bacterial and respirato-
ry tract infections. Hyper-IgM syndrome (HIGM) oc-
curs in those with deficient IgG, IgA, and IgE levels 
and normal or high levels of  IgM. Transient hypogam-
maglobulinemia of  infancy occurs in infants who ini-
tially have a low Ig level that eventually will increase to 
normal Ig levels. 
 
Early diagnosis and treatment is essential to the quality 
of  life and survival of  the patient. Diagnosis is based 
on a careful history, family history, and physical exam. 
Laboratory tests that should be obtained if  a primary 
humoral immunodeficiency is suspected include a com-
plete blood count with differential, quantitative serum 
immunoglobulin levels (IgG, IgA, and IgM), and meas-
urement of  antibody titers to vaccines5. Treatment op-
tions include immune globulin replacement therapy 
which is very effective in reducing bacterial infections, 
though of  limited availability in sub-Saharan Africa. 
Two forms of  immune globulin therapy available in-
clude intravenous (IVIG) and subctuaneous (SCIG). 
The standard initial dose of  IVIG is between 300 to 500 
mg/kg every three to four weeks. Dosing is determined 
based on the patient’s weight, trough levels of  IgG after 
treatment has started, and the clinical response of  the 
patient after treatment. Not only is an accurate diag-
nosis important for the patient, but it is also important 
for the patient’s family members who may be female 
carriers of  the disease. 
 
Review of  Literature 
A literature review shows no other reported cases of  
X-linked hypogammaglobulinemia reported in Sub-Sa-
haran Africa. This is a case of  a 9-year-old boy in sub-sa-
haran Africa, who presented with frequent and recur-
rent respiratory tract infections since infancy. Based on 
immunoglobulin level studies, it was determined that he 
had X-linked hypogammaglobulinemia. Limitations in 
making the diagnosis in sub-sarahan Africa include lack 
of  resources available for immunoglobulin testing and 
potential lack of  awareness of  the disease. However, 
with this case report, we hope to make the diagnosis 
of  X-linked hypogammaglobulinemia more known in 
sub-saharan Africa.
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